文献速递胸部肿瘤

国际肺癌研究协会间皮瘤分期项目:第九版胸膜间皮瘤TNM分类中M描述符的修订建议

The International Association for the Study of Lung Cancer Mesothelioma Staging Project: Proposals for the M Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Pleural Mesothelioma.
PubMed 文献 · J Thorac Oncol · 2024-08-23

国际肺癌研究协会建立全球多中心数据库,分析胸膜间皮瘤M分期以验证第八版建议。3221例可临床分期病例中228例(7%)为M1,M1患者中位生存10.5个月 vs M0患者21.5个月(p<0.0001),1年生存率46% vs 71%,M1亚组间无显著差异。结论支持沿用第八版M描述符,第九版不做更改。

要点

  • M1患者中位生存10.5个月,M0患者21.5个月(p<0.0001)。
  • M1与M0的1年生存率分别为46%与71%。
  • 胸腔内转移与远处转移、单器官与多器官转移的生存无显著差异。

核心结论

  • 该基于证据的胸膜间皮瘤M分期分析结果与第八版M描述符一致,第九版间皮瘤M分期不做更改。

研究设计与样本

  • 国际肺癌研究协会建立全球多中心数据库,通过电子提交或转移现有机构数据库纳入经组织学或细胞学确诊的胸膜间皮瘤患者。

主要发现

  • 7338例提交病例中3598例符合条件,3221例有足够数据进行临床分期,其中228例(7%)为M1。
  • M1患者中位总生存劣于M0患者:10.5个月 vs 21.5个月(p < 0.0001);估计1年生存率分别为46% vs 71%。
  • M分期间的总生存差异在各组织学亚组内保持不变。
  • 158例有器官特异性M1记录的患者的分析中,胸腔内转移与更远处转移的总生存无统计学显著差异(14.4个月 vs 10.9个月,p = 0.64)。
  • 单个器官系统转移与多个器官系统转移患者的总生存无显著差异(12.6个月 vs 8.8个月,p = 0.45)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The International Association for the Study of Lung Cancer developed a global multicenter database to propose evidence-based revisions for the ninth edition of the TNM classification of pleural mesothelioma (PM). This study analyzes the M category to validate eighth edition M category recommendations. METHODS: Cases were submitted electronically or by transfer of existing institutional databases for patients with histologically or cytologically confirmed PM. The presence and number of metastases (single versus multiple) in each of eight organ systems were reported for patients with M1 disease at diagnosis. Overall survival (OS) was calculated by the Kaplan-Meier method. Differences in OS were assessed by log-rank test. RESULTS: Of 7338 submitted cases, 3598 were eligible and 3221 had sufficient data for clinical staging; 228 cases (7%) were M1. Median overall estimated survival was inferior for M1 compared with M0 patients: 10.5 months versus 21.5 months, respectively (p < 0.0001); estimated 1-year survival was 46% versus 71%, respectively. OS differences between M categories were preserved within histologic subgroups. Among 158 patients with organ-specific documentation of M1 disease, there was no statistically significant difference in OS between those with intrathoracic versus more distant metastatic disease (14.4 mo versus 10.9 mo, p = 0.64). No significant survival difference was detected between patients with metastatic disease in a single-organ system versus multiple-organ systems (12.6 mo versus 8.8 mo, p = 0.45). CONCLUSIONS: This evidence-based analysis of the M category for PM conforms with the eighth edition M descriptors. No changes are proposed in the ninth edition of the mesothelioma M category.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Kindler HL, Rosenthal A, Giroux DJ, et al. The International Association for the Study of Lung Cancer Mesothelioma Staging Project: Proposals for the M Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Pleural Mesothelioma. J Thorac Oncol. 2024. PMID: 39181447. doi:10.1016/j.jtho.2024.08.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。